Currently, there are 412.19M common shares owned by the public and among those 303.50M shares have been available to trade.
The company’s stock has a 5-day price change of 21.45% and 74.21% over the past three months. AGL shares are trading 102.63% year to date (YTD), with the 12-month market performance down to -35.08% lower. It has a 12-month low price of $1.50 and touched a high of $7.73 over the same period. AGL has an average intraday trading volume of 5.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.11%, 23.37%, and -3.95% respectively.
Institutional ownership of Agilon Health Inc (NYSE: AGL) shares accounts for 71.67% of the company’s 412.19M shares outstanding.
It has a market capitalization of $1.59B and a beta (3y monthly) value of 0.54. The earnings-per-share (ttm) stands at -$0.63. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.59% over the week and 10.02% over the month.
Analysts forecast that Agilon Health Inc (AGL) will achieve an EPS of 0.01 for the current quarter, -0.03 for the next quarter and -0.19 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.03 while analysts give the company a high EPS estimate of -0.03. Comparatively, EPS for the current quarter was -0.01 a year ago. Earnings per share for the fiscal year are expected to increase by 52.13%, and 37.32% over the next financial year. EPS should grow at an annualized rate of 51.97% over the next five years, compared to 3.29% over the past 5-year period.
Looking at the support for the AGL, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on January 10, 2025, with the firm’s price target at $1.75-$2.25. Macquarie was of a view on December 16, 2024 that the stock is Neutral, while Bernstein gave the stock Mkt Perform rating on December 11, 2024, issuing a price target of $2.50. JMP Securities on their part issued Mkt Perform rating on November 11, 2024.
